{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:24:09Z","timestamp":1787127849328,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajg.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:15:15Z","timestamp":1783714515000},"page":"334-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of therapeutic targets and postoperative recurrence prediction model construction for hepatocellular carcinoma based on systematic mendelian randomization"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3817-6712","authenticated-orcid":false,"given":"Yang","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8537-8725","authenticated-orcid":false,"given":"Yizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1906-6544","authenticated-orcid":false,"given":"Qifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3824-7775","authenticated-orcid":false,"given":"Song","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.06.004_bb0005","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"issue":"12","key":"10.1016\/j.ajg.2026.06.004_bb0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajg.2026.06.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1D","key":"10.1016\/j.ajg.2026.06.004_bb0020","article-title":"Development and validation of a nomogram for predicting postoperative early relapse and survival in hepatocellular carcinoma","volume":"22","author":"He","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"46","key":"10.1016\/j.ajg.2026.06.004_bb0025","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.3748\/wjg.v28.i46.6433","article-title":"Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma","volume":"28","author":"Niu","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajg.2026.06.004_bb0030","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/med.21967","article-title":"The tumor microenvironment in the postsurgical liver: mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma","volume":"43","author":"Wu","year":"2023","journal-title":"Med Res Rev"},{"issue":"20","key":"10.1016\/j.ajg.2026.06.004_bb0035","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3748\/wjg.v28.i20.2176","article-title":"Radiomics for the detection of microvascular invasion in hepatocellular carcinoma","volume":"28","author":"Lv","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajg.2026.06.004_bb0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/HEP.0000000000000673","article-title":"Single-cell dissection of the multicellular ecosystem and molecular features underlying microvascular invasion in HCC","volume":"79","author":"Li","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2026.06.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104107","article-title":"Preoperative prediction and risk assessment of microvascular invasion in hepatocellular carcinoma","volume":"190","author":"Li","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.ajg.2026.06.004_bb0050","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajg.2026.06.004_bb0055","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2026.06.004_bb0060","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-21-1258","article-title":"NASH and hepatocellular carcinoma: immunology and immunotherapy","volume":"29","author":"Pinter","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ajg.2026.06.004_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12967-024-05109-7","article-title":"Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer","volume":"22","author":"Ma","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajg.2026.06.004_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108307","article-title":"Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis","volume":"173","author":"Wu","year":"2024","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.ajg.2026.06.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107066","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer","volume":"161","author":"Guo","year":"2023","journal-title":"Comput Biol Med"},{"issue":"4","key":"10.1016\/j.ajg.2026.06.004_bb0080","article-title":"Mendelian randomization","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajg.2026.06.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104154","article-title":"Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"82","author":"Larsson","year":"2022","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.ajg.2026.06.004_bb0090","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.ajg.2026.06.004_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"12","key":"10.1016\/j.ajg.2026.06.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.335","article-title":"Two-sample multivariable mendelian randomization analysis using R","volume":"1","author":"Rasooly","year":"2021","journal-title":"Curr Protoc"},{"key":"10.1016\/j.ajg.2026.06.004_bb0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"issue":"2","key":"10.1016\/j.ajg.2026.06.004_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2026.06.004_bb0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000001269","article-title":"Critical Update: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"82","author":"Taddei","year":"2025","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ajg.2026.06.004_bb0120","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.hpb.2022.04.007","article-title":"Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study","volume":"24","author":"Xiang","year":"2022","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.ajg.2026.06.004_bb0125","article-title":"Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with \u2018progression\/hyper-progression\u2019 recurrence","volume":"57","author":"Xu","year":"2025","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.ajg.2026.06.004_bb0130","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1111\/cas.15818","article-title":"PPAR\u03b3 inhibited tumor immune escape by inducing PD-L1 autophagic degradation","volume":"114","author":"Gou","year":"2023","journal-title":"Cancer Sci"},{"issue":"11","key":"10.1016\/j.ajg.2026.06.004_bb0135","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-\u03baB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"10.1016\/j.ajg.2026.06.004_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054974","article-title":"Host-related factors in the interplay among inflammation, immunity and dormancy in breast cancer recurrence and prognosis: an overview for clinicians","volume":"24","author":"Ruggieri","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.ajg.2026.06.004_bb0145","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.7150\/thno.56490","article-title":"ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.ajg.2026.06.004_bb0150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","article-title":"Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"56","author":"Hu","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajg.2026.06.004_bb0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.semcancer.2023.03.006","article-title":"Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma","volume":"91","author":"Luo","year":"2023","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.ajg.2026.06.004_bb0160","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1038\/s41598-024-58434-8","article-title":"A multi-omics analysis-based model to predict the prognosis of low-grade gliomas","volume":"14","author":"Du","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajg.2026.06.004_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2016.02.003","article-title":"Molecular genetics of the COL2A1-related disorders","volume":"768","author":"Deng","year":"2016","journal-title":"Mutat Res Rev Mutat Res"},{"key":"10.1016\/j.ajg.2026.06.004_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1384731","article-title":"Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer","volume":"15","author":"Ando","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajg.2026.06.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.155024","article-title":"Metalloproteinase 9 immunostaining profile is positively correlated with tumor grade, extraprostatic extension and biochemical recurrence in prostate cancer","volume":"253","author":"Pinheiro","year":"2024","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.ajg.2026.06.004_bb0180","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12885-024-12751-3","article-title":"Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression","volume":"24","author":"Wei","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajg.2026.06.004_bb0185","article-title":"Multi-transcriptomics analysis of microvascular invasion-related malignant cells and development of a machine learning-based prognostic model in hepatocellular carcinoma","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajg.2026.06.004_bb0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3350\/cmh.2023.0034","article-title":"Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging","volume":"29","author":"Hwang","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2026.06.004_bb0195","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/ijms25042150","article-title":"Minimal residual disease in acute myeloid Leukemia: old and new concepts","volume":"25","author":"Chea","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.ajg.2026.06.004_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210230","article-title":"Circulating tumor DNA as a minimal residual disease assessment and recurrence risk in patients undergoing curative-intent resection with or without adjuvant chemotherapy in colorectal cancer: a systematic review and meta-analysis","volume":"24","author":"Chidharla","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ajg.2026.06.004_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/biom11020130","article-title":"Minimal residual disease, metastasis and immunity","volume":"11","author":"Badia-Ramentol","year":"2021","journal-title":"Biomolecules"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:26:03Z","timestamp":1787124363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1687197926000687"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.06.004","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of therapeutic targets and postoperative recurrence prediction model construction for hepatocellular carcinoma based on systematic mendelian randomization","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Pan-Arab Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}